Chronic Lymphocytic Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-08-16
Clinical Trial Update: Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL [Phase 1, Phase 2]
Phase I/II trial evaluating different doses and schedules of milatuzumab (hLL1) in patients with chronic lymphocytic leukemia/lymphoma; stud…